![Antony Mattessich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antony Mattessich
Director/Board Member at
AURA BIOSCIENCES, INC.
Net worth: 287 595 $ as of 31/05/2026
Profile
Antony Mattessich is an Independent Non-Executive Director at Aura Biosciences, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Amphista Therapeutics Ltd. from 2024 to 2026, President, Chief Executive Officer & Director at Ocular Therapeutix, Inc. from 2017 to 2024, President, Chief Executive Officer & Director at Mundipharma International Ltd. in 2017, Managing Director & Director at Napp Pharmaceutical Holdings Ltd. from 2005 to 2011, Head-Therapeutic Franchise at Novartis AG from 2003 to 2005, and Head of Operations-International Medicines at Bristol Myers Squibb Co. Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0.06% | 11/06/2026 | 38,500 ( 0.06% ) | 287 595 $ | 31/05/2026 |
Antony Mattessich active positions
| Companies | Position | Start |
|---|---|---|
| AURA BIOSCIENCES, INC. | Director/Board Member | 29/09/2021 |
Former positions of Antony Mattessich
| Companies | Position | End |
|---|---|---|
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Chief Executive Officer | 18/03/2026 |
| OCULAR THERAPEUTIX, INC. | Chief Executive Officer | 15/04/2024 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Chief Executive Officer | 18/12/2017 |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops and provides medicines to patients | Chief Executive Officer | 01/05/2011 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2005 |
Training of Antony Mattessich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops and provides medicines to patients | Health Technology |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
- Stock Market
- Insiders
- Antony Mattessich
